United States · FDA National Drug Code directory
Naproxen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63187-535_bd0691c5-aaa9-472e-9b05-926d93defd0c
- Product NDC
- 63187-535
- Form
- TABLET
- Composition / generic term
- Naproxen
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070701
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 375 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET in 1 BOTTLE (63187-535-15) · 63187-535-15
- 20 TABLET in 1 BOTTLE (63187-535-20) · 63187-535-20
- 30 TABLET in 1 BOTTLE (63187-535-30) · 63187-535-30
- 45 TABLET in 1 BOTTLE (63187-535-45) · 63187-535-45
- 60 TABLET in 1 BOTTLE (63187-535-60) · 63187-535-60
- 90 TABLET in 1 BOTTLE (63187-535-90) · 63187-535-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →